medication in utero when their mothers were pregnant The United States Food and Drug Administration subsequently withdrew approval of DES as a treatment for pregnant women. It was later determined that DES can also cause other major medical complications in those exposed. In the exposed daughters of exposed women, those complications include not only the cancers previously discussed, but also an increased risk of miscarriage, premature birth, and endometriosis. References Medical controversies